{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:08:25Z","timestamp":1791803305404,"version":"4.3.4"},"reference-count":272,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["P42ES04705"],"award-info":[{"award-number":["P42ES04705"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["P01ES018172"],"award-info":[{"award-number":["P01ES018172"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002387","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01ES009137"],"award-info":[{"award-number":["R01ES009137"]}],"id":[{"id":"10.13039\/501100002387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000139","name":"U.S. Environmental Protection Agency","doi-asserted-by":"publisher","award":["RD83451101"],"award-info":[{"award-number":["RD83451101"]}],"id":[{"id":"10.13039\/100000139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bloodreviews.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.blre.2014.09.013","type":"journal-article","created":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T17:32:06Z","timestamp":1412098326000},"page":"101-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Global characteristics of childhood acute promyelocytic leukemia"],"prefix":"10.1016","volume":"29","author":[{"given":"L.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Samad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Pombo-de-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Scelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.T.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Feusner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Wiemels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Metayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2014.09.013_bb0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ctrv.2010.02.003","article-title":"Epidemiology of childhood cancer","volume":"36","author":"Kaatsch","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.blre.2014.09.013_bb0010","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1046\/j.1365-3016.2002.00422.x","article-title":"Childhood leukaemia in Costa Rica, 1981\u201396","volume":"16","author":"Monge","year":"2002","journal-title":"Paediatr Perinat Epidemiol"},{"key":"10.1016\/j.blre.2014.09.013_bb0015","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/cncr.22233","article-title":"Acute myeloid leukemia: epidemiology and etiology","volume":"107","author":"Deschler","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb0020","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00431-011-1424-7","article-title":"Molecular diagnosis and risk-adjusted therapy in pediatric hematologic malignancies: a primer for pediatricians","volume":"170","author":"Margolin","year":"2011","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.blre.2014.09.013_bb0025","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/sj.leu.2403959","article-title":"Acute myelogenous leukemia in Chile PINDA protocols 87 and 92 results","volume":"19","author":"Quintana","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.013_bb0030","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11912-009-0060-0","article-title":"Acute promyelocytic leukemia in childhood","volume":"11","author":"Gregory","year":"2009","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.blre.2014.09.013_bb0035","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0145-2126(00)00012-6","article-title":"High relative proportion of acute promyelocytic leukemia in children: experience of a multicenter study in Cuba","volume":"24","author":"Hernandez","year":"2000","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2014.09.013_bb0040","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJM199909303411407","article-title":"Acute myeloid leukemia","volume":"341","author":"Lowenberg","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2014.09.013_bb0045","series-title":"Disease Information","article-title":"Leukemias\/Lymphomas: Acute Promyelocytic Leukemia (APL)","year":"2013"},{"key":"10.1016\/j.blre.2014.09.013_bb0055","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/347558a0","article-title":"The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus","volume":"347","author":"de The","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.blre.2014.09.013_bb0060","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.172.6.1571","article-title":"Rearrangements and aberrant expression of the retinoic acid receptor alpha gene in acute promyelocytic leukemias","volume":"172","author":"Longo","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.blre.2014.09.013_bb0065","series-title":"Leukaemia Diagnosis","first-page":"1","article-title":"The Nature of Leukaemia, Cytology, Cytochemistry and the FAB Classification of Acute Leukaemia","author":"Bain","year":"2010"},{"key":"10.1016\/j.blre.2014.09.013_bb0070","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1309\/KD1G-NUR1-J75P-HQ28","article-title":"Leukemias resembling acute promyelocytic leukemia, microgranular variant","volume":"117","author":"Nagendra","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.blre.2014.09.013_bb0075","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/pbc.22087","article-title":"Tailoring treatment strategy for acute promyelocytic leukemia in low-income countries","volume":"53","author":"Rizzari","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb0080","first-page":"49","article-title":"t(17;17)(q21;q24) PRKAR1A\/RARA; del(17)(q21q24) PRKAR1A\/RARA","volume":"16","author":"Huret","year":"2011","journal-title":"Atlas Genet Cytogenet Oncol Haematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0085","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0268-960X(02)00075-9","article-title":"The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease","volume":"17","author":"Mistry","year":"2003","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2014.09.013_bb0090","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1038\/sj.leu.2402720","article-title":"Variations on a theme: the alternate translocations in APL","volume":"16","author":"Redner","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.013_bb0095","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/sj.leu.2404062","article-title":"A novel t(3;17)(p25;q21) variant translocation of acute promyelocytic leukemia with rearrangement of the RARA locus","volume":"20","author":"Redner","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.013_bb0100","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/leu.2012.371","article-title":"All-trans retinoic acid and arsenic trioxide resistance of acute promyelocytic leukemia with the variant STAT5B-RARA fusion gene","volume":"27","author":"Strehl","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.013_bb0105","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1182\/blood-2010-01-264432","article-title":"BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia","volume":"116","author":"Yamamoto","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.013_bb0110","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3324\/haematol.12854","article-title":"The seventh pathogenic fusion gene FIP1L1-RARA was isolated from a t(4;17)-positive acute promyelocytic leukemia","volume":"93","author":"Kondo","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2014.09.013_bb0115","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1182\/blood-2007-06-095554","article-title":"The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemia","volume":"110","author":"Catalano","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.013_bb0120","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1182\/blood-2012-03-362608","article-title":"Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel","volume":"120","author":"Creutzig","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.013_bb0125","first-page":"40","article-title":"Cytogenetic study of 50 de-novo cases of ANLL from Argentina","volume":"79","author":"Acevedo","year":"1994","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2014.09.013_bb0130","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue World Health Organization","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.blre.2014.09.013_bb0135","series-title":"Pediatric Oncology","first-page":"21","article-title":"Acute myeloid leukemia","author":"Imbach","year":"2011"},{"key":"10.1016\/j.blre.2014.09.013_bb0140","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.013_bb0145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000117712","article-title":"A comprehensive review of acute promyelocytic leukemia in children","volume":"119","author":"Mantadakis","year":"2008","journal-title":"Acta Haematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0150","article-title":"Management of APl in developing countries: epidemiology, challenges and opportunities for international collaboration","volume":"162","author":"Ribeiro","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.blre.2014.09.013_bb0155","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0165-4608(84)90114-6","article-title":"Chromosome patterns in 26 South African children with acute nonlymphocytic leukemia (ANLL)","volume":"11","author":"Bernstein","year":"1984","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.blre.2014.09.013_bb0160","series-title":"ASH Annual Meeting Abstracts","first-page":"4494-","article-title":"Obesity in Newly Diagnosed Childhood Acute Promyelocytic Leukemia","volume":"108","author":"Feusner","year":"2006"},{"key":"10.1016\/j.blre.2014.09.013_bb0165","series-title":"Acute Promyelocytic Leukaemia","first-page":"83","author":"Biondi","year":"2010"},{"key":"10.1016\/j.blre.2014.09.013_bb0170","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/15287390600975061","article-title":"Is age an independent risk factor for chemically induced acute myelogenous leukemia in children?","volume":"10","author":"Pyatt","year":"2007","journal-title":"J Toxicol Environ Health B"},{"key":"10.1016\/j.blre.2014.09.013_bb0175","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1200\/JCO.1993.11.6.1039","article-title":"Secondary acute myeloid leukmeia in children perviously treated with alkylating agents, interclating topoisomeraise II inhibitors and irradiation","volume":"11","author":"Sandoval","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0180","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/10428190600961736","article-title":"Secondary acute promyelocytic leukemia: an increasingly common entity","volume":"48","author":"Jantunen","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2014.09.013_bb0185","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1200\/JCO.1992.10.9.1430","article-title":"Therapy-related acute promyelocytic leukemia: a report on 16 cases","volume":"10","author":"Detourmignies","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0190","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/sj.leu.2401089","article-title":"Etoposide-related acute promyelocytic leukemia","volume":"12","author":"Kudo","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.013_bb0195","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00277-002-0552-6","article-title":"Two cases of therapy-related acute promyelocytic leukemia (t-APL) after mantle cell lymphoma and gestational trophoblastic disease","volume":"81","author":"Au","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0200","doi-asserted-by":"crossref","first-page":"e2011045","DOI":"10.4084\/mjhid.2011.045","article-title":"Molecular pathogenesis of secondary acute promyelocytic leukemia","volume":"3","author":"Joannides","year":"2011","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.blre.2014.09.013_bb0205","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa042715","article-title":"DNA topoisomerase II in therapy-related acute promyelocytic leukemia","volume":"352","author":"Mistry","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2014.09.013_bb0210","first-page":"433","article-title":"Cigarette smoking and alcohol consumption by parents of children with acute myeloid leukemia\u2014an analysis within morphological subgroups\u2014a report from the Children's Cancer Group","volume":"2","author":"Severson","year":"1993","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.blre.2014.09.013_bb0215","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1289\/ehp.11927","article-title":"Household exposure to paint and petroleum solvents, chromosomal translocations, and the risk of childhood leukemia","volume":"117","author":"Scelo","year":"2009","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.blre.2014.09.013_bb0220","first-page":"3","article-title":"Epidemiology of acute leukemia in children and adults","volume":"24","author":"Sandler","year":"1997","journal-title":"Semin Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0225","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/aje\/kwj143","article-title":"Parental smoking and the risk of childhood leukemia","volume":"163","author":"Chang","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.blre.2014.09.013_bb0230","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ijheh.2013.12.003","article-title":"Risk of leukemia in relation to exposure to ambient air toxics in pregnancy and early childhood","volume":"217","author":"Heck","year":"2014","journal-title":"Int J Hyg Environ Health"},{"key":"10.1016\/j.blre.2014.09.013_bb0235","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/pbc.22736","article-title":"Childhood leukemia incidence in Brazil according to different geographical regions","volume":"56","author":"de Souza Reis","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb0240","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/pbc.24498","article-title":"Early cardiac outcomes following contemporary treatment for childhood acute myeloid leukemia: a North American perspective","volume":"60","author":"Orgel","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb0245","first-page":"95","article-title":"Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo","volume":"9","author":"Martinez-Climent","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.013_bb0250","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/pbc.22612","article-title":"Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study","volume":"55","author":"Gorman","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb0255","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1182\/blood.V60.2.389.389","article-title":"Chromosome pattern in childhood acute nonlymphocytic leukemia (ANLL)","volume":"60","author":"Kaneko","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.013_bb0260","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1038\/sj.leu.2403872","article-title":"Successive clinical trials for childhood acute myeloid leukemia at St Jude Children's Research Hospital, from 1980 to 2000","volume":"19","author":"Ribeiro","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.013_bb0265","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/00043426-200309000-00005","article-title":"Viridans streptococcal sepsis: clinical features and complications in childhood acute myeloid leukemia","volume":"25","author":"Okamoto","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0270","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0165-4608(89)90141-6","article-title":"Cytogenetics of childhood acute nonlymphocytic leukemia","volume":"40","author":"Raimondi","year":"1989","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.blre.2014.09.013_bb0275","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0165-4608(83)90041-9","article-title":"Cytogenetic features of acute nonlymphoblastic leukemia in 73 children and adolescents","volume":"8","author":"Brodeur","year":"1983","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.blre.2014.09.013_bb0280","first-page":"295","article-title":"Acute leukemia in children: experience in Saskatchewan in 1966\u201372","volume":"113","author":"McSheffrey","year":"1975","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.blre.2014.09.013_bb0285","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.yexmp.2007.05.007","article-title":"Frequent but nonrandom expression of lymphoid markers on de novo childhood acute myeloid leukemia","volume":"83","author":"Abdelhaleem","year":"2007","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.blre.2014.09.013_bb0290","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/pbc.21706","article-title":"Defective in vitro growth of primitive hematopoietic cells from pediatric patients with acute myeloid leukemia","volume":"51","author":"Dorantes-Acosta","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb0295","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/1471-2407-11-355","article-title":"Childhood acute leukemias are frequent in Mexico City: descriptive epidemiology","volume":"11","author":"Perez-Saldivar","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb0300","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2407-5-33","article-title":"Incidence of leukemias in children from El Salvador and Mexico City between 1996 and 2000: population-based data","volume":"5","author":"Mejia-Arangure","year":"2005","journal-title":"BMC Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb0305","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/mpo.1090","article-title":"Childhood acute leukemia: a single institution experience in La Plata, Argentina","volume":"36","author":"Gomez","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0310","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/pbc.20654","article-title":"Molecular cytogenetic findings of acute leukemia included in the Brazilian Collaborative Study Group of Infant acute leukemia","volume":"47","author":"Emerenciano","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb0315","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cancergencyto.2006.05.008","article-title":"Cytogenetic and morphological findings in 166 patients with de novo acute myeloid leukemia in southern Brazil","volume":"170","author":"Onsten","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.blre.2014.09.013_bb0320","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/bjh.12250","article-title":"The distribution of MLL breakpoints correlates with outcome in infant acute leukaemia","volume":"161","author":"Emerenciano","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0325","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MPH.0b013e31818c919e","article-title":"Molecular and epidemiologic findings of childhood acute leukemia in Costa Rica","volume":"31","author":"Santamaria-Quesada","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0330","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/pbc.21399","article-title":"Nutritional status at diagnosis in children and adolescents with cancer in the Asociacion de Hemato-Oncologia Pediatrica de Centro America (AHOPCA) countries: preliminary results from Guatemala","volume":"50","author":"Sala","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb0335","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/oxfordjournals.annonc.a058400","article-title":"Childhood acute promyelocytic leukemia in Nicaragua","volume":"4","author":"Malta Corea","year":"1993","journal-title":"Ann Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0340","first-page":"329","article-title":"Acute promyelocytic leukemia in the West of Venezuela","volume":"34","author":"De Salvo","year":"1989","journal-title":"Sangre"},{"key":"10.1016\/j.blre.2014.09.013_bb0345","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1182\/blood.V97.3.805","article-title":"Multiplex reverse transcriptase-polymerase chain reaction screening in childhood acute myeloblastic leukemia","volume":"97","author":"Strehl","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.013_bb0350","series-title":"Recent Advances in Cell Biology of Acute Leukemia","first-page":"103","article-title":"Cytogenetic abnormalities associated with childhood acute myeloblastic leukemia","author":"Haas","year":"1993"},{"key":"10.1016\/j.blre.2014.09.013_bb0355","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.thromres.2011.03.014","article-title":"Epidemiology of venous thromboembolism in children with malignant diseases: a single-center study of the Belarusian Center for Pediatric Oncology and Hematology","volume":"128","author":"Lipay","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2014.09.013_bb0360","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12254-012-0059-3","article-title":"Development of treatment and clinical results in childhood acute myeloid leukemia in the Czech Republic","volume":"6","author":"Sramkova","year":"2013","journal-title":"memo\u2014Mag Eur Med Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0365","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1471-2407-6-100","article-title":"Prenatal origin of childhood AML occurs less frequently than in childhood ALL","volume":"6","author":"Burjanivova","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb0370","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/10428199909145735","article-title":"Comparative genomic hybridization and conventional cytogenetic analyses in childhood acute myeloid leukemia","volume":"35","author":"Huhta","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2014.09.013_bb0375","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/mpo.2950160402","article-title":"Cytogenetic study of 130 childhood acute nonlymphocytic leukemias","volume":"16","author":"Leverger","year":"1988","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0380","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1200\/JCO.2005.03.5303","article-title":"High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia","volume":"24","author":"Lapillonne","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0385","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1182\/blood.V65.2.298.298","article-title":"Improved Treatment results in childhood acute myelogenous leukemia\u2014a report of the German cooperative study AML-BFM-78","volume":"65","author":"Creutzig","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.013_bb0390","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cancergen.2013.01.001","article-title":"Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome","volume":"206","author":"Manola","year":"2013","journal-title":"Cancer Genet"},{"key":"10.1016\/j.blre.2014.09.013_bb0395","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12254-012-0054-8","article-title":"Development of treatment and clinical results in childhood acute myeloid leukemias in Hungary","volume":"6","author":"Szegedi","year":"2013","journal-title":"memo\u2014Mag Eur Med Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0400","first-page":"13","article-title":"Acute myeloid leukemia in childhood: 12years experience of treatment in Hungary","volume":"18","author":"Revesz","year":"1985","journal-title":"Haematologia (Budap)"},{"key":"10.1016\/j.blre.2014.09.013_bb0405","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2141.1978.tb05820.x","article-title":"Morphological diagnosis in childhood leukaemia","volume":"40","author":"Keleti","year":"1978","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0410","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1600-0609.2005.00576.x","article-title":"Multipoint interphase FISH analysis of chromosome 3 abnormalities in 28 childhood AML patients","volume":"76","author":"Haltrich","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0415","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/sj.leu.2403869","article-title":"Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols","volume":"19","author":"Pession","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.013_bb0420","first-page":"S66","article-title":"Acute promyelocytic leukemia in children\u2014experience of the Italian Pediatric Hematology and Oncology Group (AIEOP)","volume":"8","author":"Biondi","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.013_bb0425","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/pbc.22750","article-title":"Incidence of bacteremias and invasive mycoses in children with acute non-lymphoblastic leukemia: results from a multi-center Italian study","volume":"55","author":"Castagnola","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb0430","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2141.2003.04032.x","article-title":"FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemia","volume":"120","author":"Arrigoni","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0435","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1182\/blood.V81.8.2209.2209","article-title":"Diagnosis and incidence of APL in childhood","volume":"81","author":"Cantu-Rajnoldi","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.013_bb0440","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/sj.leu.2404916","article-title":"High incidence of acute promyelocytic leukemia in children in northwest Italy, 1980\u20132003: a report from the Childhood Cancer Registry of Piedmont","volume":"22","author":"Maule","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.013_bb0445","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1038\/sj.leu.2403873","article-title":"Treatment strategy and results in children treated on three Dutch Childhood Oncology Group acute myeloid leukemia trials","volume":"19","author":"Kardos","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.013_bb0450","first-page":"2856","article-title":"Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients","volume":"8","author":"de Bont","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.blre.2014.09.013_bb0455","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1203\/00006450-198305000-00016","article-title":"Chromosome studies on acute nonlymphocytic leukaemia in children","volume":"17","author":"Slater","year":"1983","journal-title":"Pediatr Res"},{"key":"10.1016\/j.blre.2014.09.013_bb0460","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12254-012-0061-9","article-title":"Development of treatment and clinical results in childhood acute myeloid leukemia in Poland","volume":"6","author":"Balwierz","year":"2013","journal-title":"Memo."},{"key":"10.1016\/j.blre.2014.09.013_bb0465","first-page":"5620","article-title":"Clinical screening of gene rearrangements in childhood leukemia by using a multiplex polymerase chain reaction-microarray approach","volume":"9","author":"Nasedkina","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.blre.2014.09.013_bb0470","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/MPH.0b013e318286d261","article-title":"NPM1, FLT3, and c-KIT mutations in pediatric acute myeloid leukemia in Russian population","volume":"35","author":"Yatsenko","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0475","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/pbc.22571","article-title":"Molecular diagnosis of childhood acute leukemia: Serbian experience","volume":"55","author":"Krstic","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb0480","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s12032-009-9261-5","article-title":"Incidence of FLT3 and nucleophosmin gene mutations in childhood acute myeloid leukemia: Serbian experience and the review of the literature","volume":"27","author":"Krstovski","year":"2010","journal-title":"Med Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0485","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/10428190903350397","article-title":"Genetic changes including gene copy number alterations and their relation to prognosis in childhood acute myeloid leukemia","volume":"51","author":"Armengol","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2014.09.013_bb0490","first-page":"290","article-title":"Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy","volume":"88","author":"Ortega","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2014.09.013_bb0495","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/CEJ.0b013e328339e2f3","article-title":"Population-based incidence of childhood leukaemias and lymphomas in Spain (1993\u20132002)","volume":"19","author":"Marcos-Gragera","year":"2010","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.blre.2014.09.013_bb0500","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/gcc.20508","article-title":"FLT3 mutations in a 10year consecutive series of 177 childhood acute leukemias and their impact on global gene expression patterns","volume":"47","author":"Andersson","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb0505","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1600-0609.2007.00854.x","article-title":"The prognostic significance of cytogenetic aberrations in childhood acute myeloid leukaemia. A study of the Swiss Paediatric Oncology Group (SPOG)","volume":"78","author":"Betts","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0510","first-page":"41","article-title":"Phenomenon of the evolution of clonal chromosomal abnormalities in childhood acute myeloid leukemia","volume":"44","author":"Andreieva","year":"2010","journal-title":"Tsitol Genet"},{"key":"10.1016\/j.blre.2014.09.013_bb0515","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/088800199277191","article-title":"Acute leukemias in children from the city of Kiev and Kiev region after the Chernobyl NPP catastrophe","volume":"16","author":"Gluzman","year":"1999","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0520","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1038\/sj.leu.2403924","article-title":"Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials","volume":"19","author":"Gibson","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.013_bb0525","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2141.1991.tb08612.x","article-title":"Acute myeloid leukaemia in childhood: the costs and benefits of intensive treatment","volume":"77","author":"Phillips","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0530","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/adc.70.3.219","article-title":"Survival from acute non-lymphocytic leukaemia, 1971\u201388: a population based study","volume":"70","author":"Stiller","year":"1994","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.blre.2014.09.013_bb0535","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1751-553X.2008.01039.x","article-title":"Prognostic significance of foetal-like tyrosine kinase 3 mutation in Egyptian children with acute leukaemia","volume":"31","author":"Al-Tonbary","year":"2009","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0540","series-title":"Report of cases presenting to CCHE 57357 in the period between 07\/07\/2007 until 31\/12\/2011(Hospital Based Cancer Registry Data)","author":"Ezzat","year":"2012"},{"key":"10.1016\/j.blre.2014.09.013_bb0545","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0609.2011.01734.x","article-title":"BIRC6\/Apollon gene expression in childhood acute leukemia: impact on therapeutic response and prognosis","volume":"88","author":"Ismail","year":"2012","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0550","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4314\/eamj.v78i7.9006","article-title":"Leukemia at the Queen Elizabeth Central Hospital in Blantyre, Malawi","volume":"78","author":"Mukiibi","year":"2001","journal-title":"East Afr Med J"},{"key":"10.1016\/j.blre.2014.09.013_bb0555","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/bjc.1982.169","article-title":"Childhood acute leukemia in a tropical population","volume":"46","author":"Williams","year":"1982","journal-title":"Br J Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb0560","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00043426-198608010-00009","article-title":"Acute childhood leukemia in Johannesburg. Ethnic differences in incidence, cell type, and survival","volume":"8","author":"Macdougall","year":"1986","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0565","first-page":"533","article-title":"Leukaemia in the Democratic Republic of Sudan","volume":"59","author":"Ahmed","year":"1982","journal-title":"East Afr Med J"},{"key":"10.1016\/j.blre.2014.09.013_bb0570","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1179\/102453312X13221316477417","article-title":"Cytogenetic profile of a large cohort of Tunisian de novo acute myeloid leukemia","volume":"17","author":"Gmidene","year":"2012","journal-title":"Hematology"},{"key":"10.1016\/j.blre.2014.09.013_bb0575","first-page":"509","article-title":"Impact of international collaboration on the prognosis of childhood acute promyelocytic leukemia in Iraq","volume":"91","author":"Testi","year":"2006","journal-title":"Haematologica-Hematol J"},{"key":"10.1016\/j.blre.2014.09.013_bb0580","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1097\/MPH.0b013e31827080fc","article-title":"Non-TBI hematopoietic stem cell transplantation in pediatric AML patients: a single-center experience","volume":"35","author":"Hamidieh","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0585","first-page":"145","article-title":"Expression profile of Wnt molecules in leukemic cells from Iranian patients with acute myeloblastic leukemia","volume":"4","author":"Memarian","year":"2007","journal-title":"Iran J Immunol"},{"key":"10.1016\/j.blre.2014.09.013_bb0590","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2141.2004.05038.x","article-title":"Classical and molecular cytogenetic abnormalities and outcome of childhood acute myeloid leukaemia: report from a referral centre in Israel","volume":"126","author":"Stark","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0595","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/08880010490273127","article-title":"Relapsed acute leukemia in children: Oman experience","volume":"21","author":"al Lamki","year":"2004","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0600","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cancergencyto.2007.05.014","article-title":"Cytogenetic, morphological, and immunophenotypic patterns in Omani patients with de novo acute myeloid leukemia","volume":"177","author":"Udayakumar","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.blre.2014.09.013_bb0605","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00043426-200001000-00006","article-title":"Extramedullary myeloid tumors in children: the limited value of local treatment","volume":"22","author":"Jenkin","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0610","first-page":"776","article-title":"Improved outcome of children with acute myeloid leukemia treated on 2 consecutive protocols","volume":"29","author":"Khattab","year":"2008","journal-title":"Saudi Med J"},{"key":"10.1016\/j.blre.2014.09.013_bb0615","first-page":"1393","article-title":"Incidence and prognostic importance of molecular genetic defects in children with acute myeloblastic leukemia","volume":"11","author":"Komur","year":"2010","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.blre.2014.09.013_bb0620","first-page":"1099","article-title":"Diagnostic value of fluorescence in situ hybridization for children with acute myeloid leukemia","volume":"20","author":"Wang","year":"2012","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.blre.2014.09.013_bb0625","doi-asserted-by":"crossref","first-page":"e2012012","DOI":"10.4084\/mjhid.2012.012","article-title":"Epidemiology, diagnosis and treatment of acute promyelocytic leukemia in children: the experience in china","volume":"4","author":"Zhang","year":"2012","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.blre.2014.09.013_bb0630","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/08880018.2010.533249","article-title":"Improved survival outcome of childhood acute myeloid leukemia with intensified chemotherapy in Chinese children","volume":"28","author":"Zhai","year":"2011","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0635","first-page":"620","article-title":"Application of recombinant human granulocyte colony stimulating factor in children with acute myeloid leukemia","volume":"112","author":"Shang","year":"1999","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.blre.2014.09.013_bb0640","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000356626","article-title":"Prophylactic first-line antibiotics reduce infectious fever and shorten hospital stay during chemotherapy-induced agranulocytosis in childhood acute myeloid leukemia","volume":"132","author":"Feng","year":"2014","journal-title":"Acta Haematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0645","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/mpo.10264","article-title":"A homoharringtonine-based regimen for childhood acute myelogenous leukemia","volume":"41","author":"Tang","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0650","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1471-2350-14-74","article-title":"The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML)","volume":"14","author":"Yan-Fang","year":"2013","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.blre.2014.09.013_bb0655","first-page":"129","article-title":"Clinical and biological characteristics of childhood acute myeloid leukemia with EVI1 gene positive expression","volume":"16","author":"Jiang","year":"2014","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"10.1016\/j.blre.2014.09.013_bb0660","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.3109\/10428194.2010.518653","article-title":"Long-term outcome of childhood acute myeloid leukemia in a developing country: experience from a children's hospital in China","volume":"51","author":"Xu","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2014.09.013_bb0665","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1038\/leu.2009.107","article-title":"Cytogenetic profile of de novo acute myeloid leukemia: a study based on 1432 patients in a single institution of China","volume":"23","author":"Cheng","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.013_bb0670","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ajh.20081","article-title":"Childhood acute myeloid leukemia with CBFbeta-MYH11 rearrangement: study of incidence, morphology, cytogenetics, and clinical outcomes of Chinese in Hong Kong","volume":"76","author":"Chan","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0675","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1182\/blood-2012-06-436782","article-title":"Cooperating gene mutations in childhood acute myeloid leukemia with special reference on mutations of ASXL1, TET2, IDH1, IDH2, and DNMT3A","volume":"121","author":"Liang","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.013_bb0680","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/MPH.0b013e31815a05aa","article-title":"The development of a novel protocol for the treatment of de novo childhood acute myeloid leukemia in a single institution in Taiwan","volume":"29","author":"Yeh","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0685","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/sj.leu.2403979","article-title":"Improved treatment results for childhood acute myeloid leukemia in Taiwan","volume":"20","author":"Liang","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.013_bb0690","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.leu.2402928","article-title":"FLT3-TKD mutation in childhood acute myeloid leukemia","volume":"17","author":"Liang","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.013_bb0695","doi-asserted-by":"crossref","first-page":"e2012042","DOI":"10.4084\/mjhid.2012.042","article-title":"Incidence of common fusion transcripts in adult and pediatric acute myeloid leukemia (AML) cases: experience of a tertiary care research institute","volume":"4","author":"Bhatia","year":"2012","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.blre.2014.09.013_bb0700","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1097\/MPH.0b013e3181f46a91","article-title":"Diagnostic and follow-up eosinophilia is not predictive of outcome in childhood acute myeloid leukemia","volume":"33","author":"Agarwal","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0705","first-page":"459","article-title":"G-banding and fluorescence in situ hybridization in childhood acute myeloid leukemia from South India","volume":"16","author":"Mir Mazloumi","year":"2013","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.blre.2014.09.013_bb0710","doi-asserted-by":"crossref","first-page":"268","DOI":"10.14238\/pi31.9-10.1991.268-72","article-title":"Acute non lymphoblastic leukemia in the Department of Child Health School of Medicine, University of North Sumatera\/Dr. Pirngadi Hospital Medan (1983\u20131988), a preliminary study","volume":"31","author":"Nasution","year":"1991","journal-title":"Paediatr Indones"},{"key":"10.1016\/j.blre.2014.09.013_bb0715","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12185-013-1364-2","article-title":"Incidence and survival rates of hematological malignancies in Japanese children and adolescents (2006\u20132010): based on registry data from the Japanese Society of Pediatric Hematology","volume":"98","author":"Horibe","year":"2013","journal-title":"Int J Hematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0720","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12185-012-1163-1","article-title":"High WT1 mRNA expression after induction chemotherapy and FLT3-ITD have prognostic impact in pediatric acute myeloid leukemia: a study of the Japanese Childhood AML Cooperative Study Group","volume":"96","author":"Shimada","year":"2012","journal-title":"Int J Hematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0725","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12185-010-0754-y","article-title":"Flow cytometric analysis of de novo acute myeloid leukemia in childhood: report from the Japanese Pediatric Leukemia\/Lymphoma Study Group","volume":"93","author":"Ohta","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0730","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1532\/IJH97.03113","article-title":"Clinical significance of minimal residual disease in childhood acute myeloid leukemia","volume":"79","author":"Miyamura","year":"2004","journal-title":"Int J Hematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0735","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/sj.leu.2402305","article-title":"Clinical relevance of in vitro chemoresistance in childhood acute myeloid leukemia","volume":"15","author":"Yamada","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.013_bb0740","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/sj.leu.2401241","article-title":"Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia. The Children's Cancer and Leukemia Study Group, Japan","volume":"13","author":"Iwai","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.013_bb0745","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/(SICI)1096-911X(199912)33:6<525::AID-MPO1>3.0.CO;2-8","article-title":"Prognostic value of internal tandem duplication of the FLT3 gene in childhood acute myelogenous leukemia","volume":"33","author":"Kondo","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0750","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1442-200X.1991.tb02579.x","article-title":"Chromosome abnormalities and prognosis in childhood acute leukemia","volume":"33","author":"Hayashi","year":"1991","journal-title":"Acta Paediatr Jpn"},{"key":"10.1016\/j.blre.2014.09.013_bb0755","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/pbc.20944","article-title":"Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group","volume":"49","author":"Tomizawa","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb0760","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0277-5379(89)90210-1","article-title":"Acute non lymphocytic leukemia is not a major type of childhood leukemia in Japan","volume":"25","author":"Bessho","year":"1989","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0765","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1365-2141.2004.05129.x","article-title":"Treating childhood acute myeloid leukaemia with the AML-BFM-83 protocol: experience in a developing country","volume":"126","author":"Chan","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0770","first-page":"187","article-title":"Patterns of hematological and non-hematological malignancies in bone marrow in a tertiary care hospital in Nepal\u201411years study","volume":"14","author":"Ghartimagar","year":"2012","journal-title":"Nepal Med Coll J"},{"key":"10.1016\/j.blre.2014.09.013_bb0775","first-page":"67","article-title":"Acute myeloblastic leukemia in children","volume":"9","author":"Asif","year":"2011","journal-title":"Int J Pathol"},{"key":"10.1016\/j.blre.2014.09.013_bb0780","article-title":"Acute myeloid leukemia in children in Pakistan\u2014an audit","volume":"247","author":"Zaki","year":"2002","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.blre.2014.09.013_bb0785","first-page":"26","article-title":"Frequency of fab subtypes in acute myeloid leukemia patients at Aga Khan University Hospital Karachi","volume":"17","author":"Harani","year":"2005","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"10.1016\/j.blre.2014.09.013_bb0790","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/pbc.20834","article-title":"Improved outcome in childhood acute myeloid leukemia in Singapore with the MRC AML 10 protocol","volume":"48","author":"Tan","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb0795","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/(SICI)1096-911X(199605)26:5<318::AID-MPO3>3.0.CO;2-L","article-title":"Survival of childhood leukemia in Singapore","volume":"26","author":"Quah","year":"1996","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0800","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1158\/1078-0432.CCR-07-0693","article-title":"Overexpression of Apollon, an antiapoptotic protein, is associated with poor prognosis in childhood de novo acute myeloid leukemia","volume":"13","author":"Sung","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.blre.2014.09.013_bb0805","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3346\/jkms.2009.24.5.904","article-title":"Unrelated hematopoietic stem cell transplantation for children with acute leukemia: experience at a single institution","volume":"24","author":"Lee","year":"2009","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.blre.2014.09.013_bb0810","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1751-553X.2007.00954.x","article-title":"Simple multiplex RT-PCR for identifying common fusion transcripts in childhood acute leukemia","volume":"30","author":"Pakakasama","year":"2008","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0815","first-page":"1827","article-title":"FLT3 and NPM1 gene mutations in childhood acute myeloblastic leukemia","volume":"12","author":"Mukda","year":"2011","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.blre.2014.09.013_bb0820","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1182\/blood.V82.12.3730.3730","article-title":"Results of intensive therapy in childhood acute myeloid leukemia, incorporating high-dose melphalan and autologous bone marrow transplantation in first complete remission","volume":"82","author":"Tiedemann","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.013_bb0825","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1445-5994.1982.tb02446.x","article-title":"Treatment of acute myeloid leukaemia in children","volume":"12","author":"Paton","year":"1982","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.blre.2014.09.013_bb0830","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1038\/sj.leu.2403925","article-title":"Long-term results of children with acute myeloid leukemia: a report of three consecutive Phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891","volume":"19","author":"Smith","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.013_bb0835","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/pbc.24942","article-title":"Outcome of children treated for relapsed acute myeloid leukemia in Central America","volume":"61","author":"Marjerrison","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb0840","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1038\/sj.leu.2403920","article-title":"Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials","volume":"19","author":"Creutzig","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.013_bb0845","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1182\/blood-2002-03-0764","article-title":"Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remission","volume":"101","author":"Locatelli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.013_bb0850","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1182\/blood-2007-09-114231","article-title":"Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study","volume":"111","author":"Forestier","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.013_bb0855","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2141.2010.08107.x","article-title":"Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline doses","volume":"149","author":"Creutzig","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0860","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0959-8049(01)00045-4","article-title":"Survival from acute non-lymphocytic leukaemia (ANLL) and chronic myeloid leukaemia (CML) in European children since 1978: a population-based study","volume":"37","author":"Gatta","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb0865","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3324\/haematol.2010.038976","article-title":"Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia","volume":"96","author":"Balgobind","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2014.09.013_bb0870","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2141.2010.08389.x","article-title":"Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984\u20132003","volume":"151","author":"Molgaard-Hansen","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0875","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2298\/ABS0501011S","article-title":"Acute leukemia of childhood\u2014a single institution's experience","volume":"57","author":"Slavkovic","year":"2005","journal-title":"Arch Biol Sci"},{"key":"10.1016\/j.blre.2014.09.013_bb0880","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0165-4608(92)90103-F","article-title":"Cytogenetic analysis in children with acute nonlymphocytic leukemia","volume":"58","author":"Petkovic","year":"1992","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.blre.2014.09.013_bb0885","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/hon.987","article-title":"FLT3 mutation and expression did not adversely affect clinical outcome of childhood acute leukaemia: a study of 531 Southeast Asian children by the Ma-Spore study group","volume":"29","author":"Leow","year":"2011","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0890","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood.V100.8.2708","article-title":"Results of consecutive trials for children newly diagnosed with acute myeloid leukemia from the Australian and New Zealand Children's Cancer Study Group","volume":"100","author":"O'Brien","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.013_bb0895","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/cncr.26190","article-title":"AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group","volume":"118","author":"Cooper","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb0900","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood.V59.5.1013.1013","article-title":"A collaborative study of the relationship of the morphological type of acute nonlymphocytic leukemia with patient age and karyotype","volume":"59","author":"Rowley","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.013_bb0905","first-page":"9","article-title":"Epidemiologia de las Leucemias en Bolivia: 1473 Casos Enero 1999 a Mayo de 2012","volume":"18","author":"Amaru","year":"2012","journal-title":"Rev Med La Paz"},{"key":"10.1016\/j.blre.2014.09.013_bb0910","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2223\/JPED.1108","article-title":"Acute myeloid leukemia in childhood: 15-year experience in a single institution","volume":"79","author":"Viana","year":"2003","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.blre.2014.09.013_bb0915","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/1097-0142(19870301)59:5<933::AID-CNCR2820590513>3.0.CO;2-R","article-title":"Acute promyelocytic leukemia. A childhood cluster","volume":"59","author":"Gilbert","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb0920","doi-asserted-by":"crossref","first-page":"6535","DOI":"10.1182\/blood-2011-05-354530","article-title":"Oral arsenic trioxide-based maintenance regimens for first complete remission of acute promyelocytic leukemia: a 10-year follow-up study","volume":"118","author":"Au","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.013_bb0925","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/08880019809028791","article-title":"All-trans-retinoic acid (ATRA): pediatric acute promyelocytic leukemia","volume":"15","author":"Bapna","year":"1998","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0930","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1182\/blood.V77.7.1418.1418","article-title":"RAR-alpha gene rearrangements as a genetic marker for diagnosis and monitoring in acute promyelocytic leukemia","volume":"77","author":"Biondi","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.013_bb0935","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.bmt.1704676","article-title":"Favorable outcome of allogeneic hematopoietic stem cell transplantation for relapsed or refractory acute promyelocytic leukemia in childhood","volume":"34","author":"Bourquin","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.blre.2014.09.013_bb0940","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/MPH.0b013e3181662493","article-title":"Pediatric acute promyelocytic leukemia: all-transretinoic acid therapy in a Brazilian pediatric hospital","volume":"30","author":"da Costa Moraes","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0945","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1200\/JCO.2004.09.008","article-title":"Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy","volume":"22","author":"de Botton","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0950","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.bbmt.2008.04.015","article-title":"Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia","volume":"14","author":"Dvorak","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2014.09.013_bb0955","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/sj.leu.2403480","article-title":"Treatment of children with newly diagnosed acute promyelocytic leukemia with arsenic trioxide: a single center experience","volume":"18","author":"George","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.013_bb0960","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1365-2141.1998.00871.x","article-title":"Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases","volume":"102","author":"Guglielmi","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0965","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2141.1997.d01-2037.x","article-title":"Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukaemia","volume":"96","author":"Hiorns","year":"1997","journal-title":"J Haematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0970","first-page":"1177","article-title":"Treatment results of intermittent and cyclic regimen with ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group","volume":"38","author":"Hirota","year":"1997","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.blre.2014.09.013_bb0975","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5045\/kjh.2010.45.4.236","article-title":"Outcome of childhood acute promyelocytic leukemia treated using a modified AIDA protocol","volume":"45","author":"Kim","year":"2010","journal-title":"Korean J Hematol"},{"key":"10.1016\/j.blre.2014.09.013_bb0980","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/pbc.24122","article-title":"FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group","volume":"59","author":"Kutny","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb0985","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/mpo.10257","article-title":"Pharmacology of all-trans-retinoic acid in children with acute promyelocytic leukemia","volume":"40","author":"Lanvers","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb0990","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/pbc.22042","article-title":"Improved outcome for Chinese children with acute promyelocytic leukemia: a comparison of two protocols","volume":"53","author":"Luo","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb0995","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1182\/blood-2004-05-1971","article-title":"GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children","volume":"106","author":"Testi","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.013_bb1000","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s12185-010-0575-z","article-title":"Retrospective study of arsenic trioxide for childhood acute promyelocytic leukemia in China: a single-center experience","volume":"91","author":"Wang","year":"2010","journal-title":"Int J Hematol"},{"key":"10.1016\/j.blre.2014.09.013_bb1005","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s12185-012-1034-9","article-title":"Quantification of PML\/RARa transcript after induction predicts outcome in children with acute promyelocytic leukemia","volume":"95","author":"Zhang","year":"2012","journal-title":"Int J Hematol"},{"key":"10.1016\/j.blre.2014.09.013_bb1010","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/pbc.21510","article-title":"Retrospective analysis of 65 Chinese children with acute promyelocytic leukemia: a single center experience","volume":"51","author":"Zhang","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb1015","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1182\/blood-2009-07-230805","article-title":"Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia","volume":"115","author":"Zhou","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.013_bb1020","first-page":"3707","article-title":"Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group Study\u2013POG 8821","volume":"94","author":"Raimondi","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.013_bb1025","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1007\/s12032-010-9642-9","article-title":"ATRA and anthracycline-based chemotherapy in the treatment of childhood acute promyelocytic leukemia (APL): a 10-year experience in Tunisia","volume":"28","author":"Jeddi","year":"2011","journal-title":"Med Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb1030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12185-011-0768-0","article-title":"Effect of arsenic trioxide on the treatment of children with newly diagnosed acute promyelocytic leukemia in China","volume":"93","author":"Zhang","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1016\/j.blre.2014.09.013_bb1035","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJM198907203210302","article-title":"Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia","volume":"321","author":"Pui","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2014.09.013_bb1040","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1056\/NEJM199112123252402","article-title":"Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia","volume":"325","author":"Pui","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2014.09.013_bb1045","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1200\/JCO.2003.09.072","article-title":"Therapy-related acute promyelocytic leukemia","volume":"21","author":"Beaumont","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb1050","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1200\/JCO.1999.17.2.569","article-title":"Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins","volume":"17","author":"Smith","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb1055","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-0041-1733149","article-title":"Therapy related acute promyelocytic leukemia","volume":"27","author":"Attili","year":"2006","journal-title":"Indian J Med Paediatr Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb1060","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1136\/jmg.2005.035253","article-title":"Spectrum and clinical implications of syntaxin 11 gene mutations in familial haemophagocytic lymphohistiocytosis: association with disease-free remissions and haematopoietic malignancies","volume":"43","author":"Rudd","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.blre.2014.09.013_bb1065","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/pbc.22718","article-title":"Acute promyelocytic leukemia following chemotherapy for EBV-associated hemophagocytic lymphohistiocytosis","volume":"56","author":"Sathiyamoorthy","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb1070","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF02780532","article-title":"Pregnancy after treatment of secondary acute promyelocytic leukemia following Hodgkin's disease: a case report","volume":"17","author":"Elezovic","year":"2000","journal-title":"Med Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb1075","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/gcc.20783","article-title":"Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: association of DNA breaks with specific DNA motifs at PML and RARA loci","volume":"49","author":"Hasan","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb1080","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2298\/SARH1106347A","article-title":"Favourable prognostic factors in therapy related acute myeloid leukaemia","volume":"139","author":"Antonijevic","year":"2011","journal-title":"Srp Arh Celok Lek"},{"key":"10.1016\/j.blre.2014.09.013_bb1085","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.leukres.2011.10.015","article-title":"Comparative molecular analysis of therapy-related and de novo acute promyelocytic leukemia","volume":"36","author":"Ottone","year":"2012","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2014.09.013_bb1090","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00043426-199302000-00013","article-title":"High frequency of etoposide (VP-16)-related secondary leukemia in children with non-Hodgkin's lymphoma","volume":"15","author":"Sugita","year":"1993","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb1095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0165-4608(90)90260-H","article-title":"Secondary acute promyelocytic leukemia with t(8;21) and t(9;22) at onset and loss of the Philadelphia chromosome at relapse","volume":"47","author":"Dallorso","year":"1990","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.blre.2014.09.013_bb1100","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/mpo.1169","article-title":"Non-identical twin sisters concordant for Langerhans cell histiocytosis and discordant for secondary acute promyelocytic leukemia","volume":"37","author":"Dufour","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb1105","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/1352458508100967","article-title":"Therapy-related acute leukaemia with Mitoxantrone: what is the risk and can we minimise it?","volume":"15","author":"Ellis","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.blre.2014.09.013_bb1110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/(SICI)1097-0215(19970328)71:1<9::AID-IJC3>3.0.CO;2-Y","article-title":"Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' cell histiocytosis in Italian and Austrian\u2013German populations","volume":"71","author":"Haupt","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb1115","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1002\/1097-0142(19931215)72:12<3723::AID-CNCR2820721226>3.0.CO;2-Y","article-title":"Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis","volume":"72","author":"Horibe","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb1120","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/sj.leu.2404443","article-title":"Two new cases of acute promyelocytic leukemia following mitoxantrone treatment in patients with multiple sclerosis","volume":"20","author":"Ledda","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.013_bb1125","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0145-2126(89)90076-3","article-title":"Specific chromosome changes and nonoccupational exposure to potentially carcinogenic agents in acute leukemia in China","volume":"13","author":"Li","year":"1989","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2014.09.013_bb1130","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/(SICI)1096-911X(199904)32:4<315::AID-MPO17>3.0.CO;2-6","article-title":"Secondary acute promyelocytic leukemia after treatment with etoposide for Langerhans cell histiocytosis (LCH)","volume":"32","author":"Lopes","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb1135","first-page":"384","article-title":"Secondary acute promyelocytic leukemia in a child treated with epipodophyllotoxins","volume":"16","author":"Lopez-Andrew","year":"1994","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb1140","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1365-2141.1994.tb04851.x","article-title":"Acute promyelocytic leukaemia in a patient treated with etoposide for Langerhans cell histiocytosis","volume":"86","author":"Matsuzaki","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.09.013_bb1145","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00043426-200407000-00005","article-title":"Secondary acute promyelocytic leukemia following chemotherapy for non-Hodgkin's lymphoma in a child","volume":"26","author":"Ogami","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb1150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jso.2930290102","article-title":"Acute leukaemia following malignant ependymoma: a case report","volume":"29","author":"Pai","year":"1985","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb1155","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1182\/blood.V78.11.2982.2982","article-title":"Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children: correlation between chromosomal abnormalities and prior therapy","volume":"78","author":"Rubin","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.013_bb1160","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/10428190500097706","article-title":"Acute promyelocytic leukemia after living donor partial orthotopic liver transplantation in two Japanese girls","volume":"46","author":"Sato","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2014.09.013_bb1165","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/mpo.1187","article-title":"Two secondary leukemias among 15 children given oral etoposide","volume":"37","author":"Schiavetti","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb1170","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/0145-2126(92)90050-H","article-title":"Specific chromosomal translocations and therapy-related leukemia induced by bimolane therapy for psoriasis","volume":"16","author":"Xue","year":"1992","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2014.09.013_bb1175","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2141.1994.tb03288.x","article-title":"Therapy-related acute promyelocytic leukaemia","volume":"86","author":"Bhavnani","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.09.013_bb1180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0165-4608(95)00163-8","article-title":"A case of therapy-related extramedullary acute promyelocytic leukemia","volume":"86","author":"Chen","year":"1996","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.blre.2014.09.013_bb1185","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.biopha.2011.10.004","article-title":"Therapy-related acute leukemia in two patients with multiple sclerosis treated with Mitoxantrone","volume":"66","author":"Colovic","year":"2012","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.blre.2014.09.013_bb1190","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/cncr.25585","article-title":"Outcome of therapy-related acute promyelocytic leukemia with or without arsenic trioxide as a component of frontline therapy","volume":"117","author":"Dayyani","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb1195","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1309\/AJCPE0MV0YTWLUUE","article-title":"Clinical and pathologic features of secondary acute promyelocytic leukemia","volume":"137","author":"Duffield","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.blre.2014.09.013_bb1200","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1600-0609.2011.01727.x","article-title":"Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy","volume":"88","author":"Elliott","year":"2012","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2014.09.013_bb1205","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1191\/1352458502ms836oa","article-title":"A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis","volume":"8","author":"Ghalie","year":"2002","journal-title":"Mult Scler"},{"key":"10.1016\/j.blre.2014.09.013_bb1210","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/oxfordjournals.annonc.a059315","article-title":"Acute promyelocytic leukaemia with t(15;17) following treatment of Hodgkin's disease\u2014a report of 4 cases","volume":"6","author":"Gillis","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb1215","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1182\/blood-2007-10-115600","article-title":"Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis","volume":"112","author":"Hasan","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.013_bb1220","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/oxfordjournals.annonc.a059316","article-title":"Therapy-related acute promyelocytic leukemia with t(15;17) (q22;q12) following chemotherapy with drugs targeting DNA topoisomerase II. A report of two cases and a review of the literature","volume":"6","author":"Hoffmann","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb1225","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1023\/A:1008375016038","article-title":"Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy","volume":"11","author":"Linassier","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb1230","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3109\/10428191003697484","article-title":"Treatment of therapy related acute promyelocytic leukemia with the combination of all trans retinoic acid and arsenic trioxide without chemotherapy: a series of three patients","volume":"51","author":"Malhotra","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2014.09.013_bb1235","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.thj.6200198","article-title":"Platinum compounds and therapy related acute promyelocytic leukemia","volume":"3","author":"Martin","year":"2002","journal-title":"Hematol J"},{"key":"10.1016\/j.blre.2014.09.013_bb1240","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/blood-2009-07-235051","article-title":"Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia","volume":"115","author":"Mays","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.013_bb1245","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0165-4608(01)00503-9","article-title":"Acute promyelocytic leukemia developing after radiotherapy for prostate cancer in a patient with chronic lymphocytic leukemia","volume":"131","author":"Molero","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.blre.2014.09.013_bb1250","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/jjco\/hyn057","article-title":"Therapy-related acute promyelocytic leukemia caused by hormonal therapy and radiation in a patient with recurrent breast cancer","volume":"38","author":"Ono","year":"2008","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb1255","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1177\/1352458509107015","article-title":"Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required","volume":"15","author":"Pascual","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.blre.2014.09.013_bb1260","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cancergencyto.2008.01.004","article-title":"Acute promyelocytic leukemia after mitoxantrone therapy for multiple sclerosis","volume":"182","author":"Ramkumar","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.blre.2014.09.013_bb1265","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ajh.20577","article-title":"Morphologic heterogeneity of acute promyelocytic leukemia: therapy-related acute promyelocytic leukemia presenting with FAB-M2 morphology","volume":"81","author":"Sinha","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2014.09.013_bb1270","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1309\/TJFFK819RPCLFKJ0","article-title":"Morphologic, cytogenetic, and molecular abnormalities in therapy-related acute promyelocytic leukemia","volume":"123","author":"Yin","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.blre.2014.09.013_bb1275","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cbi.2009.10.017","article-title":"A hospital-based case\u2013control study of acute myeloid leukemia in Shanghai: analysis of environmental and occupational risk factors by subtypes of the WHO classification","volume":"184","author":"Wong","year":"2010","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.blre.2014.09.013_bb1280","first-page":"405","article-title":"Epidemiology of acute promyelocytic leukemia","volume":"80","author":"Mele","year":"1995","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2014.09.013_bb1285","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0145-2126(01)00048-0","article-title":"Smoking and acute myeloid leukemia: associations with morphology and karyotypic patterns and evaluation of dose\u2013response relations","volume":"25","author":"Bjork","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2014.09.013_bb1290","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/sj.bjc.6600010","article-title":"Smoking and the risk of acute myeloid leukaemia in cytogenetic subgroups","volume":"86","author":"Moorman","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb1295","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1093\/jnci\/85.24.1994","article-title":"Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow","volume":"85","author":"Sandler","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.blre.2014.09.013_bb1300","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.yrtph.2009.08.007","article-title":"A hospital-based case\u2013control study of acute myeloid leukemia in Shanghai: analysis of personal characteristics, lifestyle and environmental risk factors by subtypes of the WHO classification","volume":"55","author":"Wong","year":"2009","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.blre.2014.09.013_bb1305","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/10428199409049654","article-title":"Hematopoietic malignancies and related disorders among benzene-exposed workers in China","volume":"14","author":"Travis","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2014.09.013_bb1310","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1600-0609.1998.tb01096.x","article-title":"Acute promyelocytic leukaemia: epidemiology and risk factors. A report of the GIMEMA Italian archive of adult acute leukaemia. GIMEMA Cooperative Group","volume":"61","author":"Pulsoni","year":"1998","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2014.09.013_bb1315","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/sj.leu.2400783","article-title":"Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia","volume":"11","author":"Estey","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.09.013_bb1320","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1289\/ehp.8982207","article-title":"A retrospective cohort study of leukemia and other cancers in benzene workers","volume":"82","author":"Yin","year":"1989","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.blre.2014.09.013_bb1325","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s12032-013-0625-5","article-title":"Therapy-related acute promyelocytic leukemia: a systematic review","volume":"30","author":"Rashidi","year":"2013","journal-title":"Med Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb1330","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1182\/blood-2003-01-0313","article-title":"Prenatal origin of childhood acute myeloid leukemias harboring chromosomal rearrangements t(15;17) and inv(16)","volume":"101","author":"McHale","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.09.013_bb1335","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1002\/ijc.28314","article-title":"Fetal growth and childhood acute lymphoblastic leukemia: findings from the childhood leukemia international consortium","volume":"133","author":"Milne","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.blre.2014.09.013_bb1340","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/jes.2012.115","article-title":"Exposure to herbicides in house dust and risk of childhood acute lymphoblastic leukemia","volume":"23","author":"Metayer","year":"2013","journal-title":"J Expo Sci Environ Epidemiol"},{"key":"10.1016\/j.blre.2014.09.013_bb1345","doi-asserted-by":"crossref","first-page":"854584","DOI":"10.1155\/2011\/854584","article-title":"Paternal smoking and risk of childhood acute lymphoblastic leukemia: systematic review and meta-analysis","volume":"2011","author":"Liu","year":"2011","journal-title":"J Oncol"},{"key":"10.1016\/j.blre.2014.09.013_bb1350","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s10552-012-9947-4","article-title":"Variation in xenobiotic transport and metabolism genes, household chemical exposures, and risk of childhood acute lymphoblastic leukemia","volume":"23","author":"Chokkalingam","year":"2012","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.blre.2014.09.013_bb1355","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1146\/annurev.publhealth.012809.103646","article-title":"Advances in understanding benzene health effects and susceptibility","volume":"31","author":"Smith","year":"2010","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.blre.2014.09.013_bb1360","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ije\/21.6.1063","article-title":"Occupational risk factors for acute leukaemia: a case\u2013control study","volume":"21","author":"Richardson","year":"1992","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.blre.2014.09.013_bb1365","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.canep.2012.12.011","article-title":"The Childhood Leukemia International Consortium","volume":"37","author":"Metayer","year":"2013","journal-title":"Cancer Epidemiol"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X14000824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X14000824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T07:31:20Z","timestamp":1717399880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X14000824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":272,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0268960X14000824"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2014.09.013","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global characteristics of childhood acute promyelocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2014.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}